Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

AcelRx Pharmaceuticals, Inc. ACRX

Set alert

Price alert · ACRX

All alert types
0.86 +0.86 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
14.58M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-1.10
Beta
0.52
Short ratio
4.56
Inst. own
38.88%
Dividend
0.00
Ex-div date
Earnings
Nov 8, 2023
50-d avg
0.757638
200-d avg
0.835636
1y target
4.63

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for ACRX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-25.48 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.7×
FY 2016: -2.7×FY 2017: -1.8×FY 2018: -2.9×FY 2019: -3.1×FY 2020: -2.6×FY 2021: -1.9×FY 2022: 0.4×FY 2023: -1050×FY 2024: -1.1×FY 2025: -2.7×
FY 2016 5y median -1.9× FY 2025
P/S 1397×
FY 2016: 6.8×FY 2017: 11.9×FY 2018: 62.7×FY 2019: 73.0×FY 2020: 19.5×FY 2021: 23.8×FY 2022: 9.4×FY 2023: 16.1×FY 2024: 0.0×FY 2025: 1397×
FY 2016 5y median 16.1× FY 2025
P/B 2.3×
FY 2016: -22.1×FY 2017: -2.6×FY 2018: 31.7×FY 2019: -4.0×FY 2020: -1.9×FY 2021: -1.9×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 1.9×FY 2025: 2.3×
FY 2016 5y median 0.8× FY 2025
P/FCF -3.4×
FY 2016: -3.6×FY 2017: -3.0×FY 2018: -4.5×FY 2019: -3.1×FY 2020: -2.6×FY 2021: -2.1×FY 2022: -0.6×FY 2023: -0.6×FY 2024: -1.2×FY 2025: -3.4×
FY 2016 5y median -1.2× FY 2025
EV/EBITDA -2.5×
FY 2016: -2.0×FY 2017: -1.7×FY 2018: -1.7×FY 2019: -3.6×FY 2020: -3.0×FY 2021: -2.4×FY 2022: 0.1×FY 2023: -0.5×FY 2024: -0.4×FY 2025: -2.5×
FY 2016 5y median -0.5× FY 2025
EV/Sales 1186×
FY 2016: 3.4×FY 2017: 7.7×FY 2018: 27.4×FY 2019: 79.6×FY 2020: 19.2×FY 2021: 25.9×FY 2022: 5.5×FY 2023: 7.3×FY 2024: 0.0×FY 2025: 1186×
FY 2016 5y median 7.3× FY 2025
FCF Yield -29.1%
FY 2016: -28.1%FY 2017: -33.8%FY 2018: -22.2%FY 2019: -32.7%FY 2020: -38.2%FY 2021: -47.4%FY 2022: -171.9%FY 2023: -167.8%FY 2024: -85.1%FY 2025: -29.1%
FY 2016 5y median -85.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 29.0%FY 2017: -33.3%FY 2018: -84.8%FY 2019: -197.3%FY 2020: -11.4%FY 2021: -33.2%FY 2022: -46.3%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin -48157.1%
FY 2016: -184.1%FY 2017: -483.8%FY 2018: -1660.9%FY 2019: -2368.1%FY 2020: -756.3%FY 2021: -1276.3%FY 2022: -1149.2%FY 2023: -2594.3%FY 2024: 0.0%FY 2025: -48157.1%
FY 2016 5y median -1276.3% FY 2025
Net Margin -51035.7%
FY 2016: -248.6%FY 2017: -644.3%FY 2018: -2192.0%FY 2019: -2325.9%FY 2020: -745.6%FY 2021: -1245.5%FY 2022: 2696.5%FY 2023: -1580.2%FY 2024: 0.0%FY 2025: -51035.7%
FY 2016 5y median -1245.5% FY 2025
ROE -83.9%
FY 2016: 808.6%FY 2017: 141.1%FY 2018: -1108.6%FY 2019: 128.5%FY 2020: 72.4%FY 2021: 97.8%FY 2022: 218.9%FY 2023: -72.9%FY 2024: -162.5%FY 2025: -83.9%
FY 2016 5y median -72.9% FY 2025
ROIC -52.0%
FY 2016: -34.4%FY 2017: -54.8%FY 2018: -31.6%FY 2019: -65.0%FY 2020: -70.0%FY 2021: -51.9%FY 2022: -49.4%FY 2023: -106.3%FY 2024: -97.8%FY 2025: -52.0%
FY 2016 5y median -52.0% FY 2025
ROA -48.1%
FY 2016: -43.2%FY 2017: -68.2%FY 2018: -39.1%FY 2019: -58.3%FY 2020: -60.9%FY 2021: -45.1%FY 2022: 100.6%FY 2023: -50.4%FY 2024: -71.3%FY 2025: -48.1%
FY 2016 5y median -48.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -9.9%FY 2017: -53.9%FY 2018: -73.1%FY 2019: 6.4%FY 2020: 136.6%FY 2021: -48.0%FY 2022: -37.2%FY 2023: -63.2%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 11.6%
FY 2016: -60.2%FY 2017: -21.0%FY 2018: 7.6%FY 2019: -51.7%FY 2020: 24.4%FY 2021: 12.2%FY 2022: 43.4%FY 2023: 17.0%FY 2024: 9.7%FY 2025: 11.6%
FY 2016 FY 2025
EPS (diluted) 60.9%
FY 2016: -58.8%FY 2017: -15.3%FY 2018: 26.3%FY 2019: 17.3%FY 2020: 29.9%FY 2021: 37.7%FY 2022: 197.6%FY 2023: -100.0%FY 2024: -124185.7%FY 2025: 60.9%
FY 2016 FY 2025
Free Cash Flow 10.4%
FY 2016: -54.7%FY 2017: 2.9%FY 2018: 7.1%FY 2019: -82.8%FY 2020: 26.1%FY 2021: 21.1%FY 2022: 9.8%FY 2023: 38.7%FY 2024: 27.9%FY 2025: 10.4%
FY 2016 FY 2025

Financial Health

Current Ratio 5.5×
FY 2016: 8.7×FY 2017: 4.6×FY 2018: 6.8×FY 2019: 5.3×FY 2020: 2.7×FY 2021: 3.0×FY 2022: 1.8×FY 2023: 2.6×FY 2024: 3.6×FY 2025: 5.5×
FY 2016 5y median 3.0× FY 2025
Quick Ratio 5.5×
FY 2016: 8.5×FY 2017: 4.6×FY 2018: 6.7×FY 2019: 5.0×FY 2020: 2.6×FY 2021: 2.9×FY 2022: 1.7×FY 2023: 2.6×FY 2024: 3.6×FY 2025: 5.5×
FY 2016 5y median 2.9× FY 2025
Debt / Equity 0.0×
FY 2016: -4.0×FY 2017: -0.5×FY 2018: 2.8×FY 2019: -0.7×FY 2020: -0.5×FY 2021: -0.5×FY 2022: 0.4×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 2.0×FY 2017: 0.9×FY 2018: 2.2×FY 2019: -0.3×FY 2020: 0.0×FY 2021: -0.2×FY 2022: -0.1×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: -2.6×FY 2017: -2.8×FY 2018: -2.8×FY 2019: -45.2×FY 2020: -12.4×FY 2021: -15.7×FY 2022: -18.2×FY 2023: -126×FY 2024: 38.7×FY 2025: 0.0×
FY 2016 5y median -15.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31